NME6 Antikörper (AA 1-100)
Kurzübersicht für NME6 Antikörper (AA 1-100) (ABIN872512)
Target
Alle NME6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-100
-
Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human NME6/IPIA ALPHA
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- NME6 (NME/NM23 Nucleoside Diphosphate Kinase 6 (NME6))
-
Andere Bezeichnung
- NME6
-
Hintergrund
-
Synonyms: Inhibitor of p53 induced apoptosis alpha, Inhibitor of p53-induced apoptosis-alpha, IPIA ALPHA, IPIA-alpha, NDK 6, NDK6_HUMAN, NDP kinase 6, NM23 H6, nm23-H6, NM23H6, Nme6.
Background: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate. Inhibitor of p53-induced apoptosis.Tissue specificity: Expressed at a moderately low level in many tissues. Most abundant in kidney, prostate, ovary, intestine, and spleen.
-
Gen-ID
- 10201
-
Pathways
- Nucleotide Phosphorylation, Ribonucleoside Biosynthetic Process
Target
-